Nocker Michael, Seppi Klaus, Boesch Sylvia, Donnemiller Eveline, Virgolini Irene, Wenning Gregor K, Poewe Werner, Scherfler Christoph
Department of Neurology Medical University of Innsbruck Innsbruck Austria.
Department of Nuclear Medicine Medical University of Innsbruck Innsbruck Austria.
Mov Disord Clin Pract. 2016 Nov 2;4(3):389-396. doi: 10.1002/mdc3.12446. eCollection 2017 May-Jun.
Voxel-wise comparison of [I]-2β-carbomethoxy-3beta-(4-iodophenyl)tropane ([I]β-CIT) radioligand distribution measured by single-photon emission computed tomography (SPECT) revealed distinct patterns of reduced dopamine transporter (DAT) availability in the Parkinson's variant of MSA (MSA-P). The aim of this study was to identify the monoamine transporter distribution pattern in patients with the cerebellar variant of MSA (MSA-C). Additionally, monoamine transporter availability was investigated in a small cohort of patients with sporadic adult-onset ataxia (SAOA).
[I]β-CIT SPECT was performed in patients with MSA-C (n = 12), MSA-P (n = 14), SAOA (n = 5), and controls (n = 15) matched for age. Parametric images of [I]β-CIT binding potential (BP) were generated and analyzed by statistical parametric mapping (SPM) and region of interest (ROI) analysis.
SPM localized significant reductions of [I]β-CIT BP in the striatum, midbrain, and pons in MSA-C compared to controls. When compared with MSA-P, the striatal DAT decline was significantly less affected in MSA-C. ROI analysis revealed reductions of striatal and midbrain [I]β-CIT binding in MSA-C compared to SAOA, whereas no significant difference was apparent between the SAOA and control groups.
Midbrain and pontine monoaminergic transporter binding was severely impaired in MSA-C, matching the underlying pathological features. Striatal DAT availability was relatively less affected in MSA-C compared to MSA-P, reflecting measureable, but less-profound, degeneration of the nigrostriatal dopaminergic projections. Preliminary results of reduced striatal and midbrain [I]β-CIT binding in MSA-C, compared to SAOA, suggest that the potential of DAT-SPECT as a surrogate marker in the diagnostic workup of patients with adult-onset cerebellar ataxia should be further investigated.
通过单光子发射计算机断层扫描(SPECT)测量的[I]-2β-甲氧羰基-3β-(4-碘苯基)托烷([I]β-CIT)放射性配体分布的体素级比较显示,在多系统萎缩帕金森型(MSA-P)中多巴胺转运体(DAT)可用性降低的模式明显不同。本研究的目的是确定多系统萎缩小脑型(MSA-C)患者的单胺转运体分布模式。此外,还对一小群散发性成人起病共济失调(SAOA)患者的单胺转运体可用性进行了研究。
对年龄匹配的MSA-C患者(n = 12)、MSA-P患者(n = 14)、SAOA患者(n = 5)和对照组(n = 15)进行[I]β-CIT SPECT检查。生成[I]β-CIT结合潜能(BP)的参数图像,并通过统计参数映射(SPM)和感兴趣区域(ROI)分析进行分析。
与对照组相比,SPM显示MSA-C患者纹状体、中脑和脑桥的[I]β-CIT BP显著降低。与MSA-P相比,MSA-C患者纹状体DAT下降受影响明显较小。ROI分析显示,与SAOA相比,MSA-C患者纹状体和中脑的[I]β-CIT结合减少,而SAOA组和对照组之间无明显差异。
MSA-C患者中脑和脑桥单胺能转运体结合严重受损,与潜在的病理特征相符。与MSA-P相比,MSA-C患者纹状体DAT可用性受影响相对较小,反映了黑质纹状体多巴胺能投射可测量但程度较轻的退化。与SAOA相比,MSA-C患者纹状体和中脑[I]β-CIT结合减少的初步结果表明,DAT-SPECT作为成人起病小脑共济失调患者诊断检查替代标志物的潜力应进一步研究。